Balance Sheet

Assets

173.4B

Liabilities

832.1B

Equity

Current Assets	416.8B
Cash & Short-Term Investments	266.4B
Receivables	72.6B
Other Current Assets	77.9B
Non-Current Assets	588.7B
Long-Term Investments	167.6B
PP&E	149B
Intangibles	247.5B
Other Non-Current Assets	24.5B

Current Liabilities	80.8B
Accounts Payable	16.5B
Accrued Liabilities	21.1B
Other Current Liabilities	43.3B
Non-Current Liabilities	92.5B
Other Non-Current Liabilities	92.5B

Currency: JPY

	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023
Assets
Cash & Cash Equivalents	145 320	159 587	172 142	201 275	219 973	282 567	223 814	250 178	265 049	255 966
Cash Equivalents	145 320	159 587	172 142	201 275	219 973	282 567	223 814	250 178	265 049	255 966
Short-Term Investments	14 084	14 084	34 316	0	29 739	75 900	14 089	4 017	7 219	200
Total Receivables	78 068	80 146	75 157	69 450	75 163	71 132	65 014	51 176	53 265	51 925
Accounts Receivables	78 068	80 146	75 157	69 450	75 163	71 132	65 014	51 176	53 265	51 747
Other Receivables	0	0	0	0	0	0	0	0	0	178
Inventory	27 120	27 308	26 638	27 499	26 843	29 516	43 369	46 383	44 891	53 331
Other Current Assets	16 453	12 002	11 417	10 722	4 443	10 666	9 337	5 977	8 440	14 458
Total Current Assets	281 045	289 081	319 670	308 946	356 161	469 781	355 623	357 731	378 864	375 880
PP&E Net	103 580	100 366	98 950	97 282	93 716	91 283	112 648	113 194	119 291	141 170
PP&E Gross	103 580	100 366	98 950	97 282	93 716	91 283	112 648	113 194	119 291	141 170
Accumulated Depreciation	201 510	204 583	209 439	213 599	216 880	220 434	248 739	248 482	256 113	262 155
Intangible Assets	25 787	23 151	19 817	17 604	15 769	11 768	88 642	87 920	87 290	110 441
Goodwill	22 990	22 093	19 046	16 768	15 347	12 534	133 169	128 612	125 769	128 051
Long-Term Investments	279 934	319 326	291 803	320 009	302 091	203 694	157 475	168 316	153 624	163 416
Other Long-Term Assets	15 106	14 075	9 763	10 613	16 532	32 722	17 417	21 150	23 321	22 532
Other Assets	22 990	22 093	19 046	16 768	15 347	12 534	133 169	128 612	125 769	128 051
Total Assets	728 442 N/A	768 092 +5%	759 049 -1%	771 222 +2%	799 616 +4%	821 782 +3%	864 974 +5%	876 923 +1%	888 159 +1%	941 490 +6%
Liabilities
Accounts Payable	27 859	29 133	27 082	23 327	19 939	18 814	18 045	14 672	15 101	17 001
Accrued Liabilities	15 041	14 594	14 675	13 851	14 562	13 442	23 079	18 934	15 369	18 433
Short-Term Debt	230	175	50	108	379	406	1 632	1 400	1 599	1 102
Current Portion of Long-Term Debt	0	0	103	0	0	23	182	187	690	690
Other Current Liabilities	32 920	20 217	24 736	20 811	25 419	25 768	23 518	22 473	29 518	36 552
Total Current Liabilities	76 050	64 230	66 646	58 097	60 299	58 453	66 456	57 666	62 277	73 778
Long-Term Debt	0	351	247	0	0	24	1 292	1 004	1 214	798
Deferred Income Tax	14 389	19 536	16 333	16 130	16 970	13 530	30 042	32 747	29 162	32 801
Minority Interest	11 670	13 186	13 878	15 150	16 087	11 165	29 630	28 900	19 806	22 776
Other Liabilities	26 070	30 733	32 696	31 907	31 029	25 638	27 406	27 100	27 549	24 770
Total Liabilities	128 179 N/A	128 036 0%	129 800 +1%	121 284 -7%	124 385 +3%	108 810 -13%	154 826 +42%	147 417 -5%	140 008 -5%	154 923 +11%
Equity
Common Stock	30 000	30 000	30 000	30 000	30 000	30 000	30 000	30 000	30 000	30 000
Retained Earnings	591 755	610 004	623 612	644 516	667 485	707 429	698 996	703 837	703 737	714 597
Additional Paid In Capital	15 269	15 269	15 271	15 272	15 271	14 924	0	12	0	0
Unrealized Security Profit/Loss	22 639	40 054	0	36 234	37 970	32 017	20 796	30 026	25 586	33 433
Treasury Stock	57 548	57 643	0	67 727	68 536	68 641	35 454	35 450	21 033	21 063
Other Equity	1 852	2 372	7 706	8 357	6 959	2 757	4 190	1 081	9 861	29 600
Total Equity	600 263 N/A	640 056 +7%	629 249 -2%	649 938 +3%	675 231 +4%	712 972 +6%	710 148 0%	729 506 +3%	748 151 +3%	786 567 +5%
Total Liabilities & Equity	728 442 N/A	768 092 +5%	759 049 -1%	771 222 +2%	799 616 +4%	821 782 +3%	864 974 +5%	876 923 +1%	888 159 +1%	941 490 +6%
Shares Outstanding
Common Shares Outstanding	81	81	80	80	80	80	80	80	82	82

Income Statement Balance Sheet Cash Flow Statement

Taisho Pharmaceutical Holdings Co Ltd
TSE:4581

Balance Sheet

Balance Sheet Decomposition
Taisho Pharmaceutical Holdings Co Ltd

Balance Sheet
Taisho Pharmaceutical Holdings Co Ltd

See Also

Company

Help

Tools

Stocks

Taisho Pharmaceutical Holdings Co Ltd TSE:4581

Balance Sheet

Balance Sheet Decomposition Taisho Pharmaceutical Holdings Co Ltd

Balance Sheet Taisho Pharmaceutical Holdings Co Ltd

See Also

Company

Help

Tools

Stocks

Taisho Pharmaceutical Holdings Co Ltd
TSE:4581

Balance Sheet Decomposition
Taisho Pharmaceutical Holdings Co Ltd

Balance Sheet
Taisho Pharmaceutical Holdings Co Ltd